How Does Preeclampsia Predispose to Future Cardiovascular Disease?

Current Hypertension Reports

Volumn 16, Issue 9, 2014, Pages 1-7

  Scantlebury, Dawn C ^a   Hayes, Sharonne N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Arrhythmias; Coronary heart disease; Endothelial dysfunction; Heart failure; Hypertension in pregnancy; Metabolic syndrome; Microalbuminuria; Preeclampsia; Renal failure

Indexed keywords

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HEALTH; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTOR;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; PRE-ECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTORS;

EID: 84939898498     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0472-6     Document Type: Review

References (70)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. doi:10.1016/S0140-6736(12)61728-0. Important global epidemiologic study which shifts the paradigm in our understanding of disease burden worldwide.Cardiovascular disease is now understood to be the major cause of death even in low and middle income countries, rather than communicable diseases.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–e292. doi:10.1161/01.cir.0000441139.02102.80.
3. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–31. doi:10.1097/01.AOG.0000437382.03963.88. Recently updated gudelines on hypertension in pregnancy. Of importance is the decreased emphasis on proteinuria to make the diagnosis of preeclampsia, and the inclusion of any end-organ dysfunction.
4. Dolea C, AbouZahr C. Global burden of hypertensive disorders of pregnancy in the year 2000. In: Evidence and Information for Policy (EIP), World Health Organization. 2003. http://www.who.int/healthinfo/statistics/bod_hypertensivedisordersofpregnancy.pdf.
5. Ananth CV, Lawrence CK. Pre-eclampsia and cardiovascular disease: more questions than answers? Bjog. 2013;120(8):920–3. doi:10.1111/1471-0528.12215.
6. Corwin J, Herrick WW. Relation of Hypertensive Toxemia of Pregnancy to Chronic Cardiovascular Disease. JAMA: The Journal of the American Medical Association. 1927;88(7):457. doi:10.1001/jama.1927.02680330009003.
7. Lin YS, Tang CH, Yang CY, Wu LS, Hung ST, Hwa HL, et al. Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan. Am J Cardiol. 2011;107(2):325–30. doi:10.1016/j.amjcard.2010.08.073. Large epidemiological study showing increased rates of major adverse cardiovascular events in Taiwanese women with a history of preeclampsia. Prior to this, studies such as this have been conducted in predominantly white populations.
8. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797–803. doi:10.1016/s0140-6736(05)67726-4.
9. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323(7323):1213–7.
10. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53(6):944–51. doi:10.1161/hypertensionaha.109.130765.
11. Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. Bjog. 2005;112(11):1486–91. doi:10.1111/j.1471-0528.2005.00733.x.
12. Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis. 2003;42(5):982–9.
13. Garovic VD, Bailey KR, Boerwinkle E, Hunt SC, Weder AB, Curb D, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010;28(4):826–33. doi:10.1097/HJH.0b013e328335c29a.
14. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997;77(2):154–8.
15. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357(9273):2002–6. doi:10.1016/s0140-6736(00)05112-6.
16. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326(7394):845. doi:10.1136/bmj.326.7394.845.
17. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974. doi:10.1136/bmj.39335.385301.BE.
18. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918–30. doi:10.1016/j.ahj.2008.06.042.
19. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update a guideline from the american heart association. J Am Coll Cardiol. 2011;57(12):1404–23. doi:10.1016/j.jacc.2011.02.005.
20. Mannisto T, Mendola P, Vaarasmaki M, Jarvelin MR, Hartikainen AL, Pouta A, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127(6):681–90. doi:10.1161/CIRCULATIONAHA.112.128751. Demonstration that any degree of hypertension in pregnancy is associated with an increased risk for cardiovascular disease. Previous reports conflicted on whether 'milder' forms of hypertensive pregnancy were associated with increased risk.
21. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol. 1998;147(11):1062–70.
22. Gaillard R, Steegers EA, Hofman A, Jaddoe VW. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study J Hypertens. 2011;29(5):937–44. doi:10.1097/HJH.0b013e328345500c.
23. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007;18(2):234–9. doi:10.1097/01.ede.0000254119.99660.e7.
24. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ. 2007;335(7627):978. doi:10.1136/bmj.39366.416817.BE.
25. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565. doi:10.1136/bmj.38380.674340.E0.
26. Bryson CL, Ioannou GN, Rulyak SJ, Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension. Am J Epidemiol. 2003;158(12):1148–53.
27. Ray JG, Vermeulen MJ, Schull MJ, McDonald S, Redelmeier DA. Metabolic syndrome and the risk of placental dysfunction. J Obstet Gynaecol Can. 2005;27(12):1095–101.
28. McDonald SD, Yusuf S, Walsh MW, Lonn E, Teo K, Anand SS, et al. Increased cardiovascular risk after pre-eclampsia in women with dysglycaemia. Diabetic medicine: a journal of the British Diabetic Association. 2013;30(1):e1–7. doi:10.1111/dme.12033. Even among a group of women with altered glucose homeostasis, the addition of preeclampsia confers an even higher risk of future cardiovascular disease. This association was shown to be independent of known cardiovascular risk factors, implying that preeclampsia itself may be an independent risk factor for cardiovascular disease.
29. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994;101(8):669–74.
30. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93(10):1049–59.
31. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473–82. doi:10.1016/j.placenta.2009.02.009.
32. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–58. doi:10.1172/JCI17189.
33. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642–9. doi:10.1038/nm1429.
34. Sandrim VC, Palei AC, Metzger IF, Gomes VA, Cavalli RC, Tanus-Santos JE. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension. 2008;52(2):402–7. doi:10.1161/HYPERTENSIONAHA.108.115006.
35. Craici IM, Wagner SJ, Weissgerber TL, Grande JP, Garovic VD. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int. 2014. doi:10.1038/ki.2014.17.
36. Herse F, Lamarca B. Angiotensin II Type 1 Receptor Autoantibody (AT1-AA)-Mediated Pregnancy Hypertension. Am J Reprod Immunol. 2013;69(4):413–8. doi:10.1111/aji.12072.
37. Wagner SJ, Craici IM, Grande JP, Garovic VD. From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia. Clin Nephrol. 2012;78(3):241–9.
38. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. Jama. 2001;285(12):1607–12.
39. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389–93. doi:10.1152/ajpheart.00298.2003.
40. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension. 2007;49(1):90–5. doi:10.1161/01.HYP.0000251522.18094.d4.
41. Hamad RR, Eriksson MJ, Silveira A, Hamsten A, Bremme K. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens. 2007;25(11):2301–7. doi:10.1097/HJH.0b013e3282ef5fc0.
42. Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation. 2010;122(18):1846–53. doi:10.1161/CIRCULATIONAHA.110.948455.
43. Bytautiene E, Bulayeva N, Bhat G, Li L, Rosenblatt KP, Saade GR. Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice. Am J Obstet Gynecol. 2013;208(5):388 e1–e10. doi:10.1016/j.ajog.2013.01.042. This animal model of preeclampsia demonstrated that induction of preeclampsia resulted in a plasma proteome that is associated with increased cardiovascular risk even when evaluated long after pregnancy.
44. Lerman A, Cannan CR, Higano SH, Nishimura RA, Holmes Jr DR. Coronary vascular remodeling in association with endothelial dysfunction. Am J Cardiol. 1998;81(9):1105–9.
45. Gutierrez E, Flammer AJ, Lerman LO, Elizaga J, Lerman A, Fernandez-Aviles F. Endothelial dysfunction over the course of coronary artery disease. Eur Heart J. 2013;34(41):3175–81. doi:10.1093/eurheartj/eht351.
46. Ostlund E, Al-Nashi M, Hamad RR, Larsson A, Eriksson M, Bremme K, et al. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertension research: official journal of the Japanese Society of Hypertension. 2013;36(12):1081–7. doi:10.1038/hr.2013.81.
47. Stekkinger E, Zandstra M, Peeters LL, Spaanderman ME. Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome. Obstet Gynecol. 2009;114(5):1076–84. doi:10.1097/AOG.0b013e3181b7b242.
48. Pouta A, Hartikainen A-L, Sovio U, Gissler M, Laitinen J, McCarthy MI, et al. Manifestations of Metabolic Syndrome After Hypertensive Pregnancy. Hypertension. 2004;43(4):825–31. doi:10.1161/01.hyp.0000120122.39231.88.
49. Callaway LK, McIntyre HD, O'Callaghan M, Williams GM, Najman JM, Lawlor DA. The association of hypertensive disorders of pregnancy with weight gain over the subsequent 21 years: findings from a prospective cohort study. Am J Epidemiol. 2007;166(4):421–8. doi:10.1093/aje/kwm099.
50. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol. 2009;114(5):961–70. doi:10.1097/AOG.0b013e3181bb0dfc.
51. Stekkinger E, Scholten R, van der Vlugt MJ, van Dijk AP, Janssen MC, Spaanderman ME. Metabolic syndrome and the risk for recurrent pre-eclampsia: a retrospective cohort study. Bjog. 2013;120(8):979–86. doi:10.1111/1471-0528.12189.
52. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004;175(2):189–202. doi:10.1016/j.atherosclerosis.2004.01.038.
53. Kattah AG, Asad R, Scantlebury DC, Bailey KR, Wiste HJ, Hunt SC, et al. Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens (Greenwich). 2013;15(9):617–23. doi:10.1111/jch.12116. Evidence of either persistent or recurrent renal injury many years following hypertensive pregnancy.
54. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama. 2001;286(4):421–6.
55. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9. doi:10.1056/NEJMoa0706790.
56. Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, Lin SY, et al. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ. 2013;185(3):207–13. doi:10.1503/cmaj.120230. Study demonstrating that preeclampsia-eclampsia had a very strong association with endstage renal disease (adjusted HR 14).
57. Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014;210(2):147 e1–8. doi:10.1016/j.ajog.2013.09.027. Similar findings as the above study. Women who had preeclampsia superimposed on chronic hypertension had the strongest association with end-stage renal disease.
58. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–69. doi:10.1161/01.CIR.0000095676.90936.80.
59. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc. 2008;83(11):1203–12. doi:10.4065/83.11.1203.
60. White WM, Turner ST, Bailey KR, Mosley Jr TH, Kardia SL, Wiste HJ, et al. Hypertension in pregnancy is associated with elevated homocysteine levels later in life. Am J Obstet Gynecol. 2013;209(5):454 e1–7. doi:10.1016/j.ajog.2013.06.030.
61. Visser S, Hermes W, Ket JC, Otten RH, Van Pampus MG, Bloemenkamp KW, et al. Systematic Review and Meta-analysis on Non-classic Cardiovascular Biomarkers after Hypertensive Pregnancy Disorders. Am J Obstet Gynecol. 2014. doi:10.1016/j.ajog.2014.03.032.
62. Campos O. Doppler Echocardiography During Pregnancy: Physiological and Abnormal Findings. Echocardiography. 1996;13(2):135–46.
63. Savu O, Jurcut R, Giusca S, van Mieghem T, Gussi I, Popescu BA, et al. Morphological and functional adaptation of the maternal heart during pregnancy. Circulation Cardiovascular imaging. 2012;5(3):289–97. doi:10.1161/CIRCIMAGING.111.970012.
64. Zanati Bazan SG, Borges VM, Martin LC, Magalhaes CG, Hueb JC, de Arruda Silveira LV, et al. Disproportionate Pregnancy-Induced Myocardial Hypertrophy in Women With Essential Hypertension. Am J Hypertens. 2013. doi:10.1093/ajh/hpt023.
65. Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension. 2011;57(1):85–93. doi:10.1161/HYPERTENSIONAHA.110.162321. One of the few contemporary echocardiographic studies showing myocardial structural and functional changes in preeclamptic pregnancy.
66. Ingec M, Yilmaz M, Gundogdu F. Left atrial mechanical functions in pre-eclampsia. J Obstet Gynaecol Res. 2005;31(6):535–9. doi:10.1111/j.1447-0756.2005.00332.x.
67. Melchiorre K, Sutherland GR, Watt-Coote I, Liberati M, Thilaganathan B. Severe myocardial impairment and chamber dysfunction in preterm preeclampsia. Hypertens Pregnancy. 2012;31(4):454–71. doi:10.3109/10641955.2012.697951.
68. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58(4):709–15. doi:10.1161/HYPERTENSIONAHA.111.176537. Strong evidence for persistent myocardial structural and functional changes following preeclamptic pregnancy.
69. Strobl I, Windbichler G, Strasak A, Weiskopf-Schwendinger V, Schweigmann U, Ramoni A, et al. Left ventricular function many years after recovery from pre-eclampsia. Bjog. 2011;118(1):76–83. doi:10.1111/j.1471-0528.2010.02780.x.
70. Ray JG, Schull MJ, Kingdom JC, Vermeulen MJ. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart. 2012;98(15):1136–41. doi:10.1136/heartjnl-2011-301548. Women with a history of placental syndromes have a higher risk of heart failure and arrhythmias even after adjusting for traditional risk factors. This was the first study to demonstrate this association, and gives credence to echocardiographic studies that show myocardial structural and functional changes.